Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer
- 204 Downloads
Treatment in testicular cancer survivors (TCSs) may be followed by cardiovascular disorders. We have examined whether today’s three treatment modalities are assicated with a biochemical cardiovascular risk profile.
Materials and methods
In this cross sectional study serum inflammatory markers, atherogenic lipoproteins and gonadal hormones were measured in 589 orchiectomized TCSs who have been treated 5–20 years previously. There were 140 patients treated by surgery alone (SURG), 231 who had had infradiaphragmatic radiotherapy alone (RAD), and 218 who had chemotherapy with or without additional surgery (CHEM).
(1) The RAD group had higher levels of high-sensitivity C-reactive protein and soluble CD40 ligand compared to the SURG group. (2) The CHEM group had lower levels of high density lipoprotein cholesterol and an increased apolipoprotein B/apolipoprotein A-1 ratio than the SURG group. The prevalence of metabolic syndrome was higher in the CHEM group than in the SURG group. (3) Hypogonadism was significantly more prevalent in the CHEM than in the SURG group.
Treatment for TC was related to long-term biochemical cardiovascular risk factors by different pathways: Radiation treatment is followed by elevated serum markers of chronic inflammation and endothelial dysfunction, whereas chemotherapy is followed by the development of atherogenic lipid changes and of the metabolic syndrome. This study provides justification for a prospective study of the impact of these treatment modalities on cardiovascular risk in testical cancer survivors. In the interim testicular cancer survivors should monitor cardiovascular risk over time.
KeywordsEndothelial inflammation Metabolic syndrome Hypogonadism
The Norwegian Foundation for Health and Rehabilitation. Norwegian Cancer Society. The study is part of Norwegian Urological Cancer Group. Study III. The Nord-Trøndelag Health Study (HUNT Study), a collaboration between the HUNT Research Center, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Verdal, is acknowledged.
- 8.Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001). JAMA, 285, 2486–2497.Google Scholar
- 10.Haugnes, H. S., Aass, N., Fossa, S. D., Dahl, O., Klepp, O., Wist, E. A., et al. (2007) Components of the metabolic syndrome in long-term survivors of testicular cancer. Annals of Oncology, 18, 241–248.Google Scholar
- 17.Myers, R. H., Montgomery, D. C., & Vining, G. G. (2002). Generalized linear models: With applications in engineering and the sciences. Wiley series in probability and statistics. The Family of Generalized Linear Models (pp. 169–71). New York: Wiley.Google Scholar
- 19.Nuver, J., Smit, A. J., Sleijfer, D. T., van Gessel, A. I., van Roon, A. M., van der Meer, J., et al. (2004). Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer. European Journal of Cancer, 40, 701–706.PubMedCrossRefGoogle Scholar
- 22.Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O. 3rd, Criqui, M., et al. (2003). Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Society. Circulation, 107, 499–511.PubMedCrossRefGoogle Scholar
- 28.Testis. Incidence. Counties. Survival. Cancer Registry of Norway; Institute of Population-based Cancer Research, 2001 (Accessed November 15, 2005, at http://www.kreftregisteret.no/frame.htm?forekomst_og_overlevelse_2001/testis/incidence.htm).
- 29.Thorsen, L., Nystad, W., Stigum, H., Dahl, O., Klepp, O., Bremnes, R. M., et al. (2005). The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample. Support Care Cancer, 13, 637–646.PubMedCrossRefGoogle Scholar